Tocotrienols and its impact in cardiovascular health


  • Brijendra Pratap Mishra Department of Biochemistry, Mayo Institute of Medical Sciences, Faizabad Road, Gadia, Barabanki, U.P., India
  • Z. G. Badade
  • Jhansi Lakshmi Lingidi
  • Sapna Jaiswal
  • Bhupender Kaur Anand



Tocotrienols, Cardiovascular diseases, TRF, Oxidative stress, Anti hyperlipidemic


Tocotrienols are members of the vitamin E family essential for human nutrition. It has four isomeric forms i.e., α, β, γ, δ. Palm oil and rice bran oil represent two major nutritional sources of natural tocotrienols. Taken orally, tocotrienols are bioavailable to all vital organs. Apart from tocotrienols antioxidant, anti-inflammatory, antineurodegeneration, antimicrobial, anticancer properties it also has antihypercholesterolemic and antiangiogenic properties. During the last 7 years, tocotrienol research has gained substantial momentum. More than 75% of the entire PubMed literature on tocotrienols has been published on or after 2000. This represents major swing in the overall direction of tocotrienol research. The objective of this review is to highlight the potential significance of the tocotrienol in cardiovascular diseases, mainly anti hypercholesterolemic and anti hyperlipidemic properties along with its efficacy and safety.


Whittle KJ, Dunphy PJ, Pennock JF. The isolation and properties of delta-tocotrienolfrom Hevea latex. Biochem J. 1966;100(1):138-45.

Brigelius-Flohé R, Traber MG. Vitamin E: function and metabolism. FASEB J. 1999 Jul;13(10):1145-55.

Packer Lester, Fuchs Jürgen. Vitamin E in health and disease. In: Packer Lester, Fuchs Jürgen, eds. Biochemistry and Clinical Applications. 1st ed. Chicago: CRC Press; 1993: 3.

Dormann P. Functional diversity of tocochromanols in plants. Planta. 2007;225(2):269-76.

Cerecetto H, López GV. Antioxidants derived from vitamin E: an overview. Mini Rev Med Chem. 2007 Mar;7(3):315-38.

Atkinson J. Chemical investigations of tocotrienols: isotope substitution, fluorophores and a curious curve. In: Nesaretnam K, eds. A Book. 6th ed. Kuching, Malaysia: COSTAM; 2006: 22.

Khanna S, Roy S, Slivka A, Craft TK, Chaki S, Rink C, et al. Neuroprotective properties of the natural vitamin E alphatocotrienol. Stroke. 2005b;36(10):2258-64.

Khanna S, Roy S, Parinandi NL, Maurer M, Sen CK. Characterization of the potent neuroprotective properties of the natural vitamin E alpha-tocotrienol. J Neurochem. 2006 Sep;98(5):1474-86.

Khanna S, Roy S, Ryu H, Bahadduri P, Swaan PW, Ratan RR, et al. Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem. 2003;278(44):43508-15.

Sen CK, Khanna S, Roy S, Packer L. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J Biol Chem. 2000;275(17):13049-55.

Pearce BC, Parker RA, Deason ME, Dischino DD, Gillespie E, Qureshi AA, et al. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols. J Med Chem. 1994;37(4):526-41.

Pearce BC, Parker RA, Deason ME, Qureshi AA, Wright JJ. Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem. 1992;35(20):3595-606.

Colombo ML. An update on vitamin E, tocopherol and tocotrienol-perspectives. Molecules. 2010;15(4):2103-13.

Qureshi AA, Sami SA, Salser WA, Khan FA. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis. 2002;161(1):199-207.

Serbinova E, Kagan V, Han D, Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radical Biol Med. 1991;10(5):263-75.

Constantinou C, Papas A, Constantinou AI. Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer. 2008 Aug;123(4):739-52.

Rona C, Vailati F, Berardesca E. The cosmetic treatment of wrinkles. J Cosm Dermatol. 2004 Jan;3(1):26-34.

Traber MG, Rallis M, Podda M, Weber C, Maibach HI, Packer L. Penetration and distribution of alpha-tocopherol, alpha- or gamma-tocotrienols applied individually onto murine skin. Lipids. 1998 Jan;33(1):87-91.

Weber C, Podda M, Rallis M, Thiele JJ, Traber MG, Packer L. Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced by UV-irradiation. Free Radical Biol Med. 1997;22(5):761-9.

Pruthi S, Allison TG, Hensrud DD. Vitamin E supplementation in the prevention of coronary heart disease. Mayo Clin Proceed. 2001;76(11):1131-6.

Maton Anthea. Heart disease. In: Maton Anthea, eds. Human Biology and Health. 1st ed. Englewood Cliffs, New Jersey: Prentice Hall; 1993.

United States. Chronic disease overview. United States Government, 1999. Available at:

Kris-Ethovtan P, Daniels SR, Eckel RH, Engler M, Howard BV, Krauss RM, et al. Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation. 2001;103;1034-9.

Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenecity. N Engl J Med. 1989;320:915-24.

Agarwal MK, Agarwal ML, Athar M, Gupta S. Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/BCl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle. 2004;3(2):205-11.

Sen CK, Khanna S, Rink C, Roy S. Tocotrienols: the emerging face of natural vitamin E. Vitam Horm. 2007;76:203-11.

Sundram K, Sambanthamurthi R, Tan YA. Palm fruit chemistry and nutrition. Asia Pac J Clin Nutr. 2003;12(3):355-62.

Horvath G, Wessjohann L, Bigirimana J, Jansen M, Guisez Y, Caubergs R, et al. Differential distribution of tocopherols and tocotrienols in photosynthetic and nonphotosynthetic tissues. Phytochemistry. 2006;67(12):1185-95.

Qureshi AA, Burger WC, Peterson DM, Elson CE. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem. 1986;261(23):10544-50.

Elson CE. Tropical oils: nutritional and scientific issues. Crit Rev Food Sci Nutr. 1992;31(1-2):79-102.

Panfili G, Fratianni A, Irano M. Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals. J Agric Food Chem. 2003;51(14):3940-4.

Chow CK, Draper HH. Isolation of gamma-tocotrienol dimers from Hevea latex. Biochemistry. 1970;9(2):445-50.

Sen CK, Khanna S, Roy S. Tocotrienols: vitamin E beyond tocopherols. Life Sci. 2006;78(18):2088-98.

Song BL, Debose-Boyd RA. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase stimulated by delta - and gamma - tocotrienols. J Biol Chem. 2006 Sep;281(35):25054-61.

Nesaretnam K, Guthrie N, Chambers AF, Carroll KK. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids. 1995;30(12):1139-43.

Hussein D, Mo H. d-dalta-tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas. 2009 May;38 (4):e124-36.

Chang PN, Yap WN, Lee DT, Ling MT, Wong YC, Yap YL. Evidence of gamma-tocotrienol as an apoptosis-inducing, invasion-suppressing, and chemotherapy drug-sensitizing agent in human melanoma cells. Nutr Cancer. 2009;61(3):357-66.

Sniderman A, Shaporo S, Marpole D, Teng B, Kwitervovock PO. Association of coronary atherosclerosis with hyperapolipoproteinemia. Proc NaH Acad Sci USA. 1980;77:604-8.

The expert Panel. Report of the national cholesterol education program, expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med. 1998;148:36-69.

Qureshi AA, Qureshi N, Hasler-Rapacz JO, Weber FE, Chaudhary V, Crenshaw TD, et al. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr. 1991a;53(4 Suppl):1042S-6S.

Qureshi AA, Qureshi N, Wright JJ, Shen Z, Kramer G, Gapor A, et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee) Am J Clin Nutr. 1991b;53(4 Suppl):1021S-6S.

Raederstorff D, Elste V, Aebischer C, Weber P. Effect of either gamma-tocotrienol or a tocotrienol mixture on the plasma lipid profile in hamsters. Ann Nutr Metab. 2002;46(1):17-23.

Tan DT, Khor HT, Low WH, Ali A, Gapor A. Effect of a palm-oil-vitamin E concentrate on the serum and lipoprotein lipids in humans. Am J Clin Nutr. 1991;53(4 Suppl):1027-30S.

Chen CW, Cheng HH. A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Nutr. 2006;136(6):1472-6.

Qureshi AA, Peterson DM, Hasler-Rapacz JO, Rapacz J. Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J Nutr. 2001a;131(2):223-30.

Martirosyan DM, Miroshnichenko LA, Kulakova SN, Pogojeva AV, Zoloedov VI. Amaranth oil application for coronary heart disease and hypertension. Lipids Health Dis. 2007;6(1):1.

Qureshi AA, Sami SA, Salser WA, Khan FA. Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J Nutr Biochem. 2001b;12(6):318-29.

Qureshi AA, Bradlow BA, Brace L, Manganello J, Peterson DM, Pearce BC, et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids. 1995;30(12):1171-7.

Ajuluchukwu JN, Okubadejo NU, Mabayoje My Ojini FI, Okwudiafor RN, Mbakwem AC, Fasanmade OA, et al. Comparative study of the effect of tocotrienols and a-tocopherol on fasting serum lipid profiles in patients with mild hypercholesterolaemia: a preliminary report. Niger Postgrad Med J. 2007;14:30-3.

Tomeo AC, Geller M, Watkins TR, Gapor A, Bierenbaum ML. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids. 1995;30:1179-83.

Qureshi AA, Bradlow BAY, Salser WA, Brace LD. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. J Nutr Biochem. 1997;8:290-8.

Baliarsingh S, Beg ZH, Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis. 2005;182:367-74.






Review Articles